We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SIGN:SIXSIG Group AG Analysis

Data as of 2026-06-15 - not real-time

¥172.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Signpost Corporation is trading at ¥172, comfortably below its 20‑day SMA of ¥192.7, 50‑day SMA of ¥209.1 and the 200‑day SMA of ¥269.1, indicating a pronounced bearish price trend. Technical indicators reinforce this downside bias: the RSI sits at 25.2 (deeply oversold), the MACD line is negative and diverging from its signal, and the price is hovering just above the identified support level of ¥167 while facing resistance near ¥218. Volatility is elevated at roughly 44% over the past 30 days, yet the beta is almost negligible (≈0.03), suggesting price moves are largely independent of broader market swings. On the fundamentals side, revenue grew 16.4% year‑over‑year and the company maintains a solid cash buffer of ¥1.8 bn against ¥0.49 bn of debt, but profitability remains thin with a 2.4% net margin and a modest ROE of 4.1%. Valuation metrics show a P/E of 28.9 versus an industry average of 38.2 and a DCF‑derived fair value of ¥175.4, placing the stock slightly undervalued relative to its intrinsic estimate, though the lack of dividend payout eliminates income‑focused appeal.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price remains below all major moving averages
  • RSI indicates oversold conditions that could trigger a short‑term bounce
  • Bearish MACD histogram signals continued downside pressure

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Revenue growth of 16% supports a recovery narrative
  • Valuation gap (P/E below industry) suggests upside potential
  • Strong cash position reduces financial distress risk

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic focus on AI, deep‑learning and DX aligns with long‑term market demand
  • Undervalued relative to DCF fair value and industry multiples
  • Low beta and stable cash flow provide defensive characteristics

Key Metrics & Analysis

Financial Health

Revenue Growth16.40%
Profit Margin2.42%
P/E Ratio28.9
ROE4.13%
ROA2.06%
Debt/Equity26.18
P/B Ratio1.2
Op. Cash Flow¥113.0M
Free Cash Flow¥35.6M
Industry P/E38.2

Technical Analysis

TrendBearish
RSI25.2
Support¥167.00
Resistance¥218.00
MA 20¥192.70
MA 50¥209.14
MA 200¥269.14
MACDBearish
VolumeStable
Fear & Greed Index92.43

Valuation

Fair Value¥175.39
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.03
Volatility43.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.